Psyence Group Corporate Update
June 02, 2022 07:00 ET
|
Psyence Group Inc.
Highlights: Partnership with CRO Clerkenwell Health to design and deliver Psyence’s UK clinical trial progressing; exclusive licensing agreement with Filament HealthDr. Clive Ward-Able has been...
Psyence Taps Another Pharma Exec to Drive its Clinical Program
May 31, 2022 14:50 ET
|
Psyence Group Inc.
TORONTO, May 31, 2022 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a life science biotechnology company pioneering the use of natural psychedelics...
Psyence and Filament Health Enter Into Exclusive Licensing Agreement for Natural Psilocybin Products
April 19, 2022 07:00 ET
|
Psyence Group Inc.
VANCOUVER, British Columbia, April 19, 2022 (GLOBE NEWSWIRE) -- Psyence Group Inc (CSE: PSYG | OTCQB: PSYGF) (“Psyence”), a life science biotechnology company pioneering the use of natural...
Psyence Group Announces DTC Eligibility Approval in the U.S.
February 09, 2022 07:00 ET
|
Psyence Group Inc.
TORONTO, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a life science biotechnology company pioneering the use of natural psychedelics...
Psyence Awarded ISO Certification through the British Standards Institute for its Natural Psilocybin Production Facility
February 07, 2022 07:00 ET
|
Psyence Group Inc.
TORONTO, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a life science biotechnology company pioneering the use of natural psychedelics...
Psyence looks to expand capital market opportunities in the UK and Europe
January 21, 2022 10:16 ET
|
Psyence Group Inc.
TORONTO, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a life science biotechnology company pioneering the use of natural psychedelics...
Psyence to Present at the H.C Wainwright 2nd Annual Psychedelics Conference December 6
December 03, 2021 10:30 ET
|
Psyence Group Inc.
TORONTO, Dec. 03, 2021 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a life science biotechnology company pioneering the use of natural psychedelics...
Psyence Group Announces Private Placement
December 02, 2021 17:30 ET
|
Psyence Group Inc.
TORONTO, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a life science biotechnology company pioneering the use of natural psychedelics...
Psyence Group Functional Mushroom Brand “GOODMIND™” Commences National Roll-Out in South Africa’s Largest Coffee Retail Chain
December 02, 2021 07:30 ET
|
Psyence Group Inc.
TORONTO, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a life science biotechnology company pioneering the use of natural psychedelics...
Psyence Group Inc. files Q2 Unaudited Condensed Consolidated Interim Financial Statements and MD&A
November 26, 2021 17:30 ET
|
Psyence Group Inc.
TORONTO, Nov. 26, 2021 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a life science biotechnology company with a focus on natural psychedelics in...